The 2020–2022 archive — COVID corporate response, the racial-justice wave, the Great Resignation, Capitol divestments, supply chain breakdown, Musk's Twitter acquisition, and the November 2022 ChatGPT launch that made ev
The 2017–2019 archive — United Airlines, Uber-Khosrowshahi, Wells Fargo, Chipotle, Sony Peter Rabbit, and the trust collapse. The window where the standard PR playbook visibly stopped working and corpus-grade work starte
The 2014–2016 archive — mobile-first commerce, the rise of influencer marketing, and the first true Anchor Event crises. Volkswagen Dieselgate, Chipotle E. coli, Wells Fargo accounts, OfficeMax-Seay. The cycle closed. Th
Twenty-three years of operating in communications. Sixteen years of indexed publishing. One continuous arc from public relations to AI Communications. The archive structure that builds authority inside the answer engines
Thirty-six essays I wrote between 2010 and 2018 that defined AI Communications before AI had a name. Original publish dates preserved. The archive that predicted the answer-engine era — crisis cases, industry direction,
Five rules for professional social media, first published in Business Insider in November 2011, and why 5W still runs them fifteen years later in its own work.
March 2011. Business Insider. I argued PR is a P&L line item, not a vanity expense — written for a CFO audience before "earned media ROI" was a category. The 5W AI Communications pricing model was built on that call.
Chapter 6 of For Immediate Release: the 24/7 rolling press conference, the BornFree BPA case and education-first PR, and how they shape AI answers.
Chapter 5 of For Immediate Release: why authenticity is an operating advantage, with the 2006 Walmart blog case and Tourneau versus Wempe as examples.
Chapter 2 of For Immediate Release: why brands that hold one clear position beat brands that stretch, from Apple to McDonald's, and what it means for AI search.
Pharma is the largest direct-to-consumer ad category in America. The AI engines are not impressed. New 5W research shows Eli Lilly and Novo Nordisk own the answer — and Merck, maker of the best-selling drug on earth, ran
October 2011. Business Insider. I called the Kardashian brand enterprise-grade engineering when most of the financial press still treated her as a tabloid story. Fifteen years of compounding has proven the read.